RE: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Journal of the National Cancer Institute
DOIs	https://doi.org/10.1093/jnci/djz125
Publication status	E-pub ahead of print - Jun 19 2019

Access to Document

@article{7afb32c5c681468892fa228847cecd4d,

title = "RE: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.",

author = "Rossi, {Paolo Giorgi} and Eugenio Paci",

year = "2019",

month = jun,

day = "19",

doi = "10.1093/jnci/djz125",

language = "English",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - RE: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.

AU - Rossi, Paolo Giorgi

AU - Paci, Eugenio

PY - 2019/6/19

Y1 - 2019/6/19

U2 - 10.1093/jnci/djz125

DO - 10.1093/jnci/djz125

M3 - Article

C2 - 31214709

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

ER -